A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets

Abstract The purpose of this study was to develop a method to prepare Metoprolol Succinate (MS) sustained release pellets and compress them into pellet-containing tablets without losing sustained release property. The drug layered pellets were coated with Eudragit NE 30D to obtain a sustained release (SR) property. The mechanical properties and permeability of the coating film were tailored by adjusting the proportion of talc in the coating dispersion and the weight gain of the coating film. Pellets with different MS release rates were tested and then mixed together by different ratios to optimize drug release rate. The mixed pellets were compressed into tablets with cushioning excipients. The results showed that when the ratio of talc and coating material was 1:4, the coating operation could be conducted successfully without pellet conglutination and the mechanical property of the coating film was enhanced to withstand the compress force during tableting. Blending SR-coated pellets of 20% weight gain with SR-coated pellets of 40% weight gain at the ratio of 1:5 could produce a constant and desired drug release rate. The formulation and the procedure developed in the study were suitable to prepare MS pellet-containing tablets with selected SR properties.

[1]  J. Sjögren,et al.  Design of a new multiple-unit controlled-release formulation of metoprolol — Metoprolol CR , 2004, European Journal of Clinical Pharmacology.

[2]  Benjamin A. Carreras,et al.  On the applicability of Fick's law to diffusion in inhomogeneous systems , 2005 .

[3]  Jukka Ilkka,et al.  Prediction of the compression behaviour of powder mixtures by the Heckel equation , 1993 .

[4]  L. Augsburger,et al.  Effect of different excipients on the tableting of coated particles , 1994 .

[5]  P. Schmidt,et al.  Compression of enteric-coated pellets to disintegrating tablets , 1996 .

[6]  C. Goodman.  United States Pharmacopeial Convention , 1988 .

[7]  A. Hirschfelder.  THE UNITED STATES PHARMACOPEIAL CONVENTION , 1930 .

[8]  Tablets ZOMIG-ZMT,et al.  Orally Disintegrating Tablets , 2013 .

[9]  Sunil B Jaiswal,et al.  A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS). , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[10]  K. Klotz,et al.  Comparative pharmacology of human β-adrenergic receptor subtypes—characterization of stably transfected receptors in CHO cells , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[11]  Joseph B. Schwartz,et al.  Compaction Studies on Beads: Compression and Consolidation Parameters , 1994 .

[12]  R. Bodmeier,et al.  Compression of pellets coated with various aqueous polymer dispersions. , 2004, International journal of pharmaceutics.

[13]  Jm Newton,et al.  Comparative gastrointestinal transit of pellet systems of varying density , 1995 .

[14]  R. Bodmeier,et al.  Mechanical Properties of Dry and Wet Cellulosic and Acrylic Films Prepared from Aqueous Colloidal Polymer Dispersions Used in the Coating of Solid Dosage Forms , 1994, Pharmaceutical Research.

[15]  B. Lilley,et al.  Deformation of Particles during Briquetting , 1970, Nature.

[16]  L. Chan,et al.  Influence of storage conditions and type of plasticizers on ethylcellulose and acrylate films formed from aqueous dispersions. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[17]  Nobuya Kaneko,et al.  Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets , 2012, Drug development and industrial pharmacy.

[18]  S. Nazzal,et al.  Novel use of Eudragit NE 30D/Eudragit L 30D-55 blends as functional coating materials in time-delayed drug release applications. , 2008, International journal of pharmaceutics.